James Tulsky receives award from American Cancer Society

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JAMES TULSKY received the Pathfinder in Palliative Care Award from the American Cancer Society.

Tulsky is chief of Duke Palliative Care and professor of medicine and nursing at Duke University.

Presented at the Kathleen Foley Palliative Care Research Retreat, the award recognizes innovation and ingenuity in contributing to the advancement of the palliative care field. Tulsky received the award for his work on oncologist-patient communication; being an advocate for palliative and supportive care research; and his mentorship of faculty in palliative care research.

In the 1990s, Tulsky was the first to examine how residents and faculty talk to patients about resuscitative choices. His landmark study identified major deficiencies in communication and he became a leader in developing interventions to improve clinician communication skills. This led to the development of an NCI-funded online intervention which improved the oncologist’s ability to identify and respond to empathic opportunities and improved trust between clinician and patient.

He was also a member of the Institute of Medicine committee that recently authored the study on “Dying in America,” which recommended major changes to care for seriously ill patients.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login